The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
TalkRADIO is absolute waffle
The lack of self-awareness is quite breathtaking
If RM is reading this, the HTA ‘Stamp’ at the bottom of the page has a typo.
‘Licensed by the Human Tissure Authority’
The data
https://twitter.com/rowlsmanthorpe/status/1349459843833352192?s=21
The data shows that transmission through non-compliance is highest amongst those who don’t properly self isolate. It follows that people don’t properly self isolate because they are unable to afford time off work due to SSP. It seems a sensible step to me, if we are serious about preventing the spread.
Personally, I would probably prefer that the issues with SSP are dealt with full stop but I can’t see this government unpicking that issue. Therefore, the next best thing is this....particularly as the press can whip it up into a covid cash point style headline which distracts from the real issue by inviting the nation to look at a dead cat...and all because somebody can’t afford the short time off work.
Amazon have written an open letter to Joe Biden
https://www.reuters.com/article/us-amazon-com-vaccine-idUSKBN29P2KO
70%
I think you need to keep going with the research:
DMC
EUA ? May
Home Trial
ACTIV 2
PROTECT
Production
Recruitment
“Warp Speed” will be folded in to Kessler’s portfolio, which will be broader than vaccine development, one official said.
Good!
Thanks Porky, it just seemed as though you were asking some questions that would have been addressed by looking at that information. I appreciate it’s a lot to absorb overnight and there is nothing wrong with using the bb to ask questions and supplement knowledge so I apologise if my tone was a little off.
One point on production, they are planning to scale up beyond 100k per month and commenced recruitment to manage this to start in the Summer. Don’t be dismayed by the Summer because they have consultants working on it today.
In addition, if (when) we get on Activ2, the US could throw money at us to support manufacture.
Comparing NCYT and SNG is pointless and in any case NCYT are just about to report and let’s see what happens to the SP there when they do.
*mind
Great post Matml, my only addition to it would be that if we get a good read out from UK home trial and if (when) we get on Activ 2 and a good read out there, and if we get on PROTECT and a good read out there we will have built data sets that go towards proving broad spectrum anti-viral and I don’t think we can put a value on that.
I accept there are a few ifs there but there is growing confidence in the Science so no reason to suspect we won’t get good read outs from p3 and Activ2 and Prof Holgate seems bullish about prophylactic use too and he hasn’t been wrong so far.
All of these results could land within a 3 - 4 month window and at the back end of that window we will also have data from the long covid end points of the p3 trial - another very valuable dataset.
So in a few short months we could be sitting on something very special indeed and £10 will be a distant memory.
I’ve tried not to be rampy and use the conditional in my notes here but in my own made I replace a lot of the ‘ifs’ with ‘when’s’ and ‘coulds’ with ‘wills’.
Cheers SCINV, I appreciate you taking the time out to share some useless nonsense with us
Andy, you would have to ask SCINV, matters such as this are beyond us mere mortals.
Porky hasn’t bothered to watch the videos or articles I guided them to the last time he asked for research.
Nice work indeed Oxford, it would be really great to see us on this trial and provide another dataset towards proving broad spectrum use.
Nice work again Dafad
Starved of news :)
Don't worry about it, when you mentioned and then confirmed I had to recheck, particularly because of the latest TR1, but no harm done...we are up there and that's no bad thing :)